Open AccessCYP21A2 gene mutationsin the women with recurrent miscarriage
Author(s) -
Natalya Sergeevna Osinovskaya,
Осиновская Наталья Сергеевна,
Iskender Yuryevich Sultanov,
Султанов Искендер Юрьевич,
T. Ivaschenko,
Иващенко Татьяна Эдуардовна,
Vladislav Baranov,
Баранов Владислав Сергеевич
Publication year - 2012
Publication title -
žurnalʺ akušerstva i ženskihʺ boleznej
Language(s) - English
Resource type - Journals
eISSN - 1684-0461
pISSN - 1683-9366
DOI - 10.17816/jowd613104-108
Subject(s) - congenital adrenal hyperplasia , medicine , population , gynecology , miscarriage , obstetrics , recurrent miscarriage , pregnancy , hyperandrogenism , mutation , gene , genetics , endocrinology , biology , obesity , insulin resistance , environmental health , polycystic ovary
Miscarriage is one of the major problems of modern reproduction. Total frequency of micarrieges is estimated as 15–27 % of total pregnancies. Recurrent Miscarriage (RM) (three or more spontaneous abortions) is responsible for almost 20 % of total miscarrieges. The population frequency of RM fluctuates from 2 % to 5 %. One of the important causes of abortion in the first trimester are hormonal disturbances in the mother, including adrenal hyperandrogenism, which results in congenital adrenal hyperplasia (CAH). In 95 % of cases, this pathology is caused by mutations in the 21-hydroxylase gene (CYP21A2), encoding for 21-hydroxylase. A non-classical form of CAH is the leading factor in 30 % of RM in women with hyperandrogenia. The aim of this study was to investigate the role of the most common mutations in the CYP21A2 gene in women with RM for more accurate diagnosis of this pathology. The level of 17-OH-progesterone was measured in women with RM and with mutations in the gene CYP21A2. The frequency of mutations in the CYP21A2 gene in RM women was significantly higher than in the group of women who don’t have these mutations (14.4 ± 3.3 % and 2 ± 1.4 %, respectively, p <0,05 df = 1). According to the odds ratio the risk of RM in CYP21A2 mutations carriers is 8 times higher than in the women without these mutations (OR = 8.4 (1.9–37.6)). The level of 17-OH-progesterone is not associated with mutations in CYP21A2 gene in the women with RM